Aptahem’s presentation at the BioStock Life Science Summit now available
Aptahem’s CEO Mikael Lindstam presented the company and gave an update on the ongoing activities at the BioStock Life Science Summit on 31 May 2023.The presentation, which is held in English, is now available at the company’s website: https://aptahem.com/videos/video-category/presentations/ For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@aptahem.com About Aptahem Aptahem AB (APTA) is a clinical stage biotechnology company that develops aptamer-based pharmaceuticals for the treatment of acute, life-threatening conditions in which